Quantcast

Peanut Allergy Treatment Via Oral Immunotherapy

January 31, 2014

Peanut allergy affects more than 10 million people around the world and is the most common disorder linked to allergy deaths. But experts from the University of Cambridge might have a solution. The team took a pool of children and built up their tolerance to peanuts over a six-month period using oral immunotherapy. At the end of the trial period, 84% to 91% of participants could eat 800 mg of peanut protein on a daily basis—25 times more than they could eat before the study began. And if you or someone you know has a peanut allergy, you know how revolutionary that is. It means that parents of these kids can go out to a restaurant and not have to stress over whether the food’s cooked in peanut oil. But experts say the approach isn’t ready to be implemented far and wide, but it’s a significant step.

[ Read the Article: Cambridge Team Finds Huge Success In Peanut Allergy Treatments ]



comments powered by Disqus